AKT1 and kidney disorder: Recent reports showed that the PI3K/AKT/GSK-3β pathway has been reported involved in cell proliferation (Chan et al., 2018), apoptosis (Xie et al., 2017), and inflammation (Jing et al., 2017) in various kidney diseases.